STOCKHOLDER’S AGREEMENT DATED AS OF AMONG PAPA MURPHY’S HOLDINGS, INC. AND LEP PAPA MURPHY’S HOLDINGS, LLC
Exhibit 10.2
STOCKHOLDER’S AGREEMENT
DATED AS OF
[•], 2014
AMONG
PAPA ▇▇▇▇▇▇’▇ HOLDINGS, INC.
AND
LEP PAPA ▇▇▇▇▇▇’▇ HOLDINGS, LLC
THIS STOCKHOLDER’S AGREEMENT (this “Agreement”)
dated as of [•], 2014 among:
(i) Papa ▇▇▇▇▇▇’▇ Holdings Inc., a Delaware corporation (the “Company”); and
(ii) LEP Papa ▇▇▇▇▇▇’▇ Holdings, LLC (collectively, with its permitted assignees as contemplated by Section 4.01(b), “▇▇▇ Equity”).
W I T N E S S E T H :
WHEREAS, in connection with underwritten initial public offering of Common Stock of the Company (the “Initial Public Offering”), it is the intention of the parties hereto to enter into this Agreement to govern ▇▇▇ Equity’s rights with respect to the Company.
NOW, THEREFORE, for good and valuable consideration the sufficiency and adequacy of which is hereby acknowledged, the parties hereto agree as follows:
ARTICLE 1
DEFINITIONS
SECTION 1.01. Definitions.
(a) The following terms, as used herein, have the following meanings:
“Affiliate” means, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under common control with such Person; provided that no securityholder of the Company shall be deemed an Affiliate of any other securityholder solely by reason of an investment in the Company. For the purpose of this definition, the term “control” (including, with correlative meanings, the terms “controlling”, “controlled by” and “under common control with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise.
“Board” means the board of directors of the Company.
“Business Day” means any day except a Saturday, Sunday or other day on which commercial banks in New York City are authorized by law to close.
“Change in Control” means any transaction whereby (i) any Person or Persons or “group” (other than ▇▇▇ Equity and its Affiliates) becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, in one or a series of transactions, of more than 50% of the total voting power or economic interest of the Company (or any entity which controls the Company or
which is a successor to all or substantially all of the assets of the Company), including by way of issuance, merger, consolidation, tender or exchange offer or otherwise, or (ii) all or substantially all of the consolidated assets of the Company and its Subsidiaries are sold to any Person or Persons or “group” (other than ▇▇▇ Equity and its Affiliates). For the avoidance of doubt, neither the Initial Public Offering nor any secondary public offering shall be deemed a Change in Control.
“Charter” means the Fifth Amended and Restated Certificate of Incorporation of the Company, as the same may be amended from time to time.
“Common Stock” means the Company’s common stock, par value $0.01 per share, and any stock into which such Common Stock may thereafter be converted, changed, reclassified or exchanged.
“Company Securities” means (i) the Common Stock, (ii) any preferred stock, (iii) any other common stock issued by the Company and (iv) any securities convertible into or exchangeable for, or options, warrants or other rights to acquire, Common Stock or any other common stock issued by the Company.
“Credit Agreement” means that certain Credit Agreement, dated as of October 25, 2013, by and among PMI Holdings Inc. as borrower and the lender parties thereto, as in effect as of the date hereof (and without giving effect to any future modification, amendment or supplement thereof).
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
“▇▇▇ Equity Nominees” means the members of the Board designated by ▇▇▇ Equity.
“Leverage Ratio” has the meaning ascribed to such term in the Credit Agreement.
“Person” means an individual, corporation, limited liability company, partnership, association, trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof.
“Securities Act” means the Securities Act of 1933, as amended.
“Stockholder” means each Person (other than the Company) who, at any relevant determination date, shall be a party to or bound by this Agreement (as may be amended from time to time) so long as such Person shall “beneficially own” (as such term is defined in Rule 13d-3 of the Exchange Act) any Company Securities.
“Subsidiary” means, with respect to any Person, any entity of which securities or other ownership interests having ordinary voting power to elect a majority of the board of directors or other persons performing similar functions are at the time directly or indirectly owned by such Person.
2
“Transfer” means, with respect to any Company Securities, (i) when used as a verb, to sell, assign, dispose of, exchange, pledge, encumber, hypothecate or otherwise transfer such Company Securities or any participation or interest therein, whether directly or indirectly, or agree or commit to do any of the foregoing and (ii) when used as a noun, a direct or indirect sale, assignment, disposition, exchange, pledge, encumbrance, hypothecation, or other transfer of such Company Securities or any participation or interest therein or any agreement or commitment to do any of the foregoing.
(b) Other Definitional and Interpretive Matters. Unless otherwise expressly provided, for purposes of this Agreement, the following rules of interpretation shall apply:
Headings. The provision of a Table of Contents, the division of this Agreement into Articles, Sections and other subdivisions and the insertion of headings are for convenience of reference only and shall not affect or be utilized in construing or interpreting this Agreement. All references in this Agreement to any “Section” are to the corresponding Section of this Agreement unless otherwise specified.
Herein. The words such as “herein,” “hereinafter,” “hereof,” and “hereunder” refer to this Agreement as a whole and not merely to a subdivision in which such words appear unless the context otherwise requires.
Including. Wherever the word “include,” “includes,” or “including” is used in this Agreement, it shall be deemed to be followed by the words “without limitation”.
ARTICLE 2
CORPORATE GOVERNANCE
SECTION 2.01. Board of Directors; Board Nominees; Committees.
(a) Concurrently with the Initial Public Offering, the Board shall consist of seven (7) directors comprised of the following: (i) the ▇▇▇ Equity Nominees shall be ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, Yoo ▇▇▇ ▇▇▇, ▇▇▇▇▇▇ ▇. ▇▇▇, and Achi ▇▇▇▇▇ (ii) the independent director shall be ▇▇▇▇ ▇▇▇▇▇▇ and (iii) the final two (2) directors shall be ▇▇▇ ▇▇▇▇▇▇▇ and ▇▇▇▇ ▇▇▇▇. The Chairman of the Board shall be ▇▇▇▇ ▇▇▇▇. No later than the first anniversary of the Initial Public Offering, the Board shall be increased in size to nine (9) directors and shall be comprised of the following: (i) the ▇▇▇ Equity Nominees shall be [ ] and [ ], (ii) the independent directors shall be ▇▇▇▇ ▇▇▇▇▇▇ and four (4) other independent directors, and (iii) the final two directors shall be ▇▇▇ ▇▇▇▇▇▇▇ and ▇▇▇▇ ▇▇▇▇.
(b) From and after the first anniversary of the Initial Public Offering, so long as ▇▇▇ Equity owns: (i) 20% or more of the issued and outstanding Common Stock of the Company (excluding any subsequent acquisition of Common Stock, other
3
than Common Stock acquired from the Company in a privately negotiated transaction), ▇▇▇ Equity shall be entitled to designate to the Board at least two (2) of the Board’s nine (9) directors or (ii) less than 20%, but at least 10% of the issued and outstanding Common Stock of the Company (excluding any subsequent acquisition of Common Stock, other than Common Stock acquired from the Company in a privately negotiated transaction), ▇▇▇ Equity shall be entitled to designate to the Board at least one (1) of the Board’s nine (9) directors.
(c) The Company agrees to cause each individual designated pursuant to this Section 2.01 or Section 2.02 to be nominated to serve as a director on the Board, or as Chairman of the Board, and to take all other necessary actions (including calling a special meeting of the Board and/or stockholders or expanding the size of the Board) to ensure that the composition of the Board is as set forth in this Section 2.01 and to otherwise implement the provisions of this Section 2.01 and Section 2.02. For the avoidance of doubt, the Company agrees to expand the size of the Board to ensure that that the composition of the Board is as set forth in Sections 2.01(a) and 2.01(b).
SECTION 2.02. Vacancies. If, as a result of death, disability, retirement, resignation, removal or otherwise, there shall exist or occur any vacancy of a ▇▇▇ Equity Nominee on the Board, ▇▇▇ Equity may designate another individual (the “Replacement Nominee”) to fill such vacancy and serve as a director on the Board.
SECTION 2.03. Reimbursement of Director Expenses. The Company shall reimburse all reasonable and documented out-of-pocket expenses incurred by the ▇▇▇ Equity Nominees in connection with traveling by first or business class on a commercial air carrier to and from and attending meetings of the Board and while conducting business at the request of the Company.
SECTION 2.04. Corporate Opportunities. In furtherance of, and without limiting what is set forth in the Charter, except as may be otherwise expressly agreed in writing by the Company and ▇▇▇ Equity and its Affiliates, the Company, on behalf of itself and its subsidiaries, renounces any interest or expectancy of the Company and its subsidiaries in, or in being offered an opportunity to participate in, business opportunities, which are from time to time presented to ▇▇▇ Equity or any of its managers, officers, directors, agents, stockholders, members, partners, Affiliates and subsidiaries (other than the Company and its Subsidiaries), even if the opportunity is one that the Company or its Subsidiaries might reasonably be deemed to have pursued or had the ability or desire to pursue if granted the opportunity to do so, and no such person or entity shall be liable to the Company or any of its Subsidiaries for breach of any fiduciary or other duty, as a director or officer or otherwise, by reason of the fact that such person or entity pursues or acquires such business opportunity, directs such business opportunity to another person or entity or fails to present such business opportunity, or information regarding such business opportunity, to the Company or its Subsidiaries unless, in the case of any such person who is a director or officer of the Company, such business opportunity is expressly offered to such director or officer in writing solely in his or her capacity as a director or officer of the Company. The alteration, amendment, addition to
4
or repeal of this Section 2.04, shall not eliminate or reduce the effect of this Section 2.04 in respect of any business opportunity first identified or any other matter occurring, or any cause of action, suit or claim that, but for this Section 2.04, would accrue or arise, prior to such alteration, amendment, addition, repeal or adoption.
SECTION 2.05. Approvals. For so long as ▇▇▇ Equity and its Affiliates own 25% or more of the issued and outstanding Common Stock of the Company (excluding any subsequent acquisition of Common Stock, other than Common Stock acquired from the Company in a privately negotiated transaction), the Company and its Subsidiaries shall not take any of the following actions without the prior written consent of ▇▇▇ Equity:
(a) issue Company Securities or equity securities of any of the Company’s Subsidiaries other than the granting of options or shares of Common Stock to members of the Company’s management or the issuance of shares of Common Stock in connection with the exercise of such options;
(b) declare or pay any non-pro rata dividends or other non-pro rata distributions in respect of the Company Securities;
(c) incur any indebtedness for borrowed money (other than indebtedness incurred under that certain existing revolver of up to $10,000,000 under the Credit Agreement or in connection with the refinancing of the Company’s existing indebtedness) that would cause the Leverage Ratio to exceed 4.5x at the time of such incurrence;
(d) effect any merger, recapitalization, issuance of Company Securities or other adjustment in voting rights, in one or any series of related transactions, if such event would result in a Change in Control of the Company;
(e) adopt a new equity-based incentive plan, make any increase to the maximum number of shares of Common Stock available to participants in the Company’s existing equity-based incentive plans or materially change the vesting schedule, or terminate any of the Company’s existing equity-based incentive plans;
(f) make any material investment in, or acquire or dispose of, any material assets or entity (other than investments in wholly-owned subsidiaries), in each case in excess of $25,000,000, or enter into any material joint ventures, partnerships or similar arrangements;
(g) hire or terminate the employment of the Chief Executive Officer of the Company (the “CEO”);
(h) materially increase the salary of the CEO (other than increases for standard cost of living adjustments) or make any material change to the bonus structure applicable to the CEO as is in effect as of the date hereof;
5
(i) amend the Charter or bylaws of the Company in any manner adverse to ▇▇▇ Equity;
(j) materially change the Company’s business of being the owner and/or franchisor of stores and restaurants that sell or serve pizza and other food items; or
(k) change the number of directors of the Company.
ARTICLE 3
CONFIDENTIAL INFORMATION
SECTION 3.01. Confidentiality.
(a) The Company acknowledges and agrees that (i) ▇▇▇ Equity may disclose Confidential Information to its Affiliates, representatives and advisors, (ii) any ▇▇▇ Equity Nominee may disclose Confidential Information to ▇▇▇ Equity and its Affiliates, representatives and advisors, (iii) ▇▇▇ Equity and its Affiliates may disclose Confidential Information if requested or required by law, judicial or governmental order, deposition, interrogatory, subpoena, civil investigation, demand, discovery request or similar process (provided that if such disclosure is requested rather than required under applicable law, ▇▇▇ Equity shall, to the extent permitted by applicable law, promptly notify the Company prior to any such disclosure to the extent practicable and cooperate with the Company, at the Company’s sole cost and expense, in any attempts it may make to obtain a protective order or other appropriate assurance that confidential treatment will be afforded the Confidential Information) and (iv) for so long as ▇▇▇ Equity own 10% or more of the issued and outstanding Common Stock of the Company (excluding any subsequent acquisition of Common Stock, other than Common Stock acquired from the Company in a privately negotiated transaction), ▇▇▇ Equity and its Affiliates (a) will be granted access to customary non-public information of the Company and members of the Company’s management team as reasonably requested by ▇▇▇ Equity and (b) may disclose Confidential Information to any potential purchaser of the Company that executes a customary confidentiality agreement that includes a prohibition on trading on material non-public information (and ▇▇▇ Equity shall provide the Company with prompt written notice after execution thereof). Except as set forth in this Section 3.01, ▇▇▇ Equity will not disclose Confidential Information to any third party.
(b) “Confidential Information” shall mean any confidential or proprietary information relating to the business or affairs of the Company or any of its Affiliates, including, but not limited to, information relating to financial statements, customer identities, potential customers, employees, sales representatives, suppliers, servicing methods, equipment programs, strategies and information, analyses, profit margins or other proprietary information used by the Company or any of its Affiliates; provided, however, that Confidential Information does not include any information which is in the public domain or becomes known in the industry through no wrongful act on the part of ▇▇▇ Equity; provided that Confidential Information shall not include information that (i) is or becomes generally known to the public other than as a result of a disclosure
6
by ▇▇▇ Equity in violation of this Agreement, (ii) is or was available to ▇▇▇ Equity on a non-confidential basis prior to its disclosure to ▇▇▇ Equity, or (iii) was or becomes available to ▇▇▇ Equity on a non-confidential basis from a source other than the Company or a Board member, which source is or was (at the time of receipt of the relevant information) not bound by a confidentiality agreement with the Company or another person.
ARTICLE 4
MISCELLANEOUS
SECTION 4.01. Binding Effect; Assignability; Benefit.
(a) This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective heirs, successors, legal representatives and permitted assigns.
(b) Neither this Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof shall be assignable by any party hereto pursuant to any Transfer of Company Securities or otherwise; provided, however, that in connection with any Transfer of Company Securities by ▇▇▇ Equity (i) to any of its Affiliates or (ii) of 10% or more of the issued and outstanding Common Stock of the Company in a privately negotiated transaction (a “Third Party Transfer”), in each case ▇▇▇ Equity may assign all or any portion of its rights as set forth in Article 2 and Article 3 to any such transferee who agrees to be bound by this Agreement; provided, further, however, that in the case of a Third Party Transfer, the requisite ownership thresholds set forth in this Agreement shall apply to such third party transferee based on the number of shares of Common Stock of the Company received by such third party transferee from ▇▇▇ Equity in such Third Party Transfer (and excluding any prior or subsequent acquisitions of Common Stock by such transferee via an open market transaction). ▇▇▇ Equity shall provide the Company with prompt written notice following a Third Party Transfer. Except for Section 2.04 and Section 4.12, nothing in this Agreement, expressed or implied, is intended to confer on any Person other than the parties hereto, and their respective heirs, successors, legal representatives and permitted assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement.
SECTION 4.02. Notices. All notices, requests and other communications to any party shall be in writing and shall be delivered in person, mailed by certified or registered mail, return receipt requested, or sent by facsimile transmission,
If to the Company, to:
Papa ▇▇▇▇▇▇’▇ Holdings, Inc.
▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Attention: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇
Fax: (▇▇▇) ▇▇▇-▇▇▇▇
7
If to ▇▇▇ Equity, to:
▇▇▇ Equity Partners, LLC
▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇
Attention: Yoo ▇▇▇ ▇▇▇
Fax: (▇▇▇)▇▇▇-▇▇▇▇
In each case with a copy to:
Weil, Gotshal & ▇▇▇▇▇▇ LLP
▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇
Attention: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Esq.
Fax: (▇▇▇) ▇▇▇-▇▇▇▇
or, in each case, at such other address or fax number as such party may hereafter specify for the purpose of notices hereunder by written notice to the other parties hereto. All notices, requests and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior to 5:00 p.m. in the place of receipt and such day is a Business Day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received until the next succeeding Business Day in the place of receipt. Any notice, request or other written communication sent by facsimile transmission shall be confirmed by certified or registered mail, return receipt requested, posted within one (1) Business Day, or by personal delivery, whether courier or otherwise, made within two (2) Business Days after the date of such facsimile transmissions.
Any Person that hereafter becomes a Stockholder shall provide its address and fax number to the Company, which shall promptly provide such information to each other Stockholder.
SECTION 4.03. Waiver; Amendment; Termination.
(a) No provision of this Agreement may be waived except by an instrument in writing executed by the party against whom the waiver is to be effective. No provision of this Agreement may be amended or otherwise modified except by an instrument in writing executed by the Company and ▇▇▇ Equity.
(b) This Agreement shall terminate upon, (i) the written request of ▇▇▇ Equity or (ii) such time as ▇▇▇ Equity or its Affiliates or any transferee of ▇▇▇ Equity or its Affiliates who agrees to be bound by this Agreement pursuant to Section 4.01(b) owns less than 10% in the aggregate of the issued and outstanding Common Stock of the Company.
8
SECTION 4.04. Fees and Expenses. The Company shall pay the costs and expenses incurred in connection with (i) the preparation, negotiation and execution of this Agreement and (ii) ▇▇▇ Equity’s enforcement of its rights and remedies set forth in this Agreement.
SECTION 4.05. Governing Law. This Agreement, and all claims or causes of action (whether at law, in equity, in contract, in tort or otherwise) based upon, arising out of, related to or otherwise in connection with this Agreement or the transactions contemplated hereby, shall be exclusively governed by, and construed in accordance with, the internal laws of the State of Delaware, without giving effect to principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of laws of another jurisdiction (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter into this Agreement).
SECTION 4.06. Jurisdiction. The parties hereby agree that any suit, action or proceeding (whether at law, in equity, in contract, in tort or otherwise) seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter into this Agreement) shall be exclusively brought in the United States District Court for the Southern District of New York or any New York State court sitting in New York City, so long as one of such courts shall have subject matter jurisdiction over such suit, action or proceeding, and that any case of action arising out of this Agreement shall be deemed to have arisen from a transaction of business in the State of New York, and each of the parties hereby irrevocably consents to the exclusive jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding which is brought in any such court has been brought in an inconvenient forum. Process in any such suit, action or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing, each party agrees that service of process on such party as provided in Section 4.03 shall be deemed effective service of process on such party.
SECTION 4.07. Waiver of Jury Trial. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING (WHETHER AT LAW, IN EQUITY, IN CONTRACT, IN TORT OR OTHERWISE) ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
SECTION 4.08. Specific Enforcement; Cumulative Remedies. The parties hereto acknowledge that money damages may not be an adequate remedy for violations of this Agreement and that any party, in addition to any other rights and
9
remedies which the parties may have hereunder or at law or in equity, may, in his or its sole discretion, apply to a court of competent jurisdiction for specific performance or injunction or such other relief as such court may deem just and proper in order to enforce this Agreement or prevent any violation hereof and, to the extent permitted by applicable law, each party waives any objection to the imposition of such relief. All rights, powers and remedies provided under this Agreement or otherwise available in respect hereof at law or in equity shall be cumulative and not alternative, and the exercise or beginning of the exercise of any thereof by any party shall not preclude the simultaneous or later exercise of any other such rights, powers or remedies by such party.
SECTION 4.09. Entire Agreement. This Agreement and any exhibits and other documents referred to herein constitute the entire agreement and understanding among the parties hereto in respect of the subject matter hereof and thereof and supersede all prior and contemporaneous agreements and understandings, both oral and written, among the parties hereto, or between any of them, with respect to the subject matter hereof and thereof.
SECTION 4.10. Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated. Upon such a determination, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner so that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible.
SECTION 4.11. Counterparts; Effectiveness. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.
SECTION 4.12. No Recourse. Notwithstanding anything that may be expressed or implied in this Agreement, and notwithstanding the fact that the entity comprising ▇▇▇ Equity is a limited liability company, each party to this Agreement covenants, agrees and acknowledges that no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement shall be had against any of ▇▇▇ Equity’s current or future directors, officers, employees, general or limited partners, members, managers or trustees, or any partner, member, manager or trustee, as such, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any of ▇▇▇ Equity’s current or future officers, agents, employees, directors, managers, members, or any Affiliates or assignees thereof, as such, for any obligation of ▇▇▇ Equity under this Agreement or any documents or instruments delivered in connection with this Agreement for any claim based on, in
10
respect of or by reason of such obligations or their creation (in each case, except in the case of any such Person trading on material non-public Confidential Information in violation of Section 3.01 and applicable law).
[The remainder of this page is intentionally left blank.]
11
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.
| PAPA ▇▇▇▇▇▇’▇ HOLDINGS, INC. | ||
| By: | ||
| Name: | ||
| Title: | ||
| LEP PAPA ▇▇▇▇▇▇’▇ HOLDINGS, LLC | ||
| By: | ||
| Name: | ||
| Title: | ||
[SIGNATURE PAGE TO STOCKHOLDER’S AGREEMENT]